Patents Examined by Nutter Nathan M.
  • Intravascular embolizing agent containing angiogenesis-inhibiting substance
    Patent number: 5202352
    Abstract: The present invention relates to an intravascular embolizing agent containing an angiogenesis-inhibiting substance and an intravascular embolizing substance. The agent strengthens the antitumor effect of an angiogenesis-inhibiting substance and serves to reduce the dose and undesirable side effects. And use of the agent in concert with an anti-neoplastic agent brings about further strong and long-lasting antitumor effects.
    Type: Grant
    Filed: August 6, 1991
    Date of Patent: April 13, 1993
    Assignee: Takeda Chemical Industries, Ltd.
    Inventors: Hiroaki Okada, Shigeru Kamei, Toshio Yoshioka